Jane Street
VNRX icon

Jane Street’s VolitionRx Ltd VNRX Stock Holding History

Jane Street’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,571
Closed -$28.5K – 13110
2025
Q4 		$28.5K Buy
+5,571
New +$42.3K ﹤0.01% 10654
2024
Q1 		– Sell
-736
Closed -$10.6K – 10157
2023
Q4 		$10.6K Sell
736
-373
-34% -$5.48K ﹤0.01% 8963
2023
Q3 		$15.3K Buy
+1,109
New +$27.4K ﹤0.01% 8339
2023
Q2 		– Sell
-1,310
Closed -$50K – 9637
2023
Q1 		$50K Buy
+1,310
New +$54.8K ﹤0.01% 8452
2021
Q3 		– Sell
-1,319
Closed -$87K – 10802
2021
Q2 		$87K Buy
+1,319
New +$89.2K ﹤0.01% 9324
2020
Q4 		– Sell
-606
Closed -$38K – 8168
2020
Q3 		$38K Sell
606
-1,884
-76% -$128K ﹤0.01% 6959
2020
Q2 		$194K Buy
2,490
+954
+62% +$68.9K ﹤0.01% 6394
2020
Q1 		$96K Buy
+1,536
New +$128K ﹤0.01% 4951

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Jane Street's VNRX Position: Q1 2026 in Review

Jane Street sold out of VolitionRx Ltd (VNRX) in Q1 2026, closing a stake of 5,571 shares — an estimated $28.5K sold.

Jane Street first reported a position in VNRX in Q1 2020 and held it in 8 quarters. The position peaked at $194K in Q2 2020. 31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

  • Jane Street reported no remaining VolitionRx Ltd position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 5,571 VolitionRx Ltd shares in Q1 2026, an estimated $28.5K.
  • Jane Street first reported a position in VolitionRx Ltd in Q1 2020 and held it in 8 quarters.
  • Jane Street's VolitionRx Ltd position peaked at $194K in Q2 2020.
  • 31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.